Navigation Links
Tobacco constituent extraction from snus during consumer use
Date:4/1/2013

Scientists at British American Tobacco have used a multi-analyte approach to determine the level of exposure to tobacco constituents of snus users. The results show that, generally, less than a third of each constituent measured was extracted by consumers during use.

Snus is a moist snuff that is placed under the upper lip. Epidemiological evidence, particularly from Sweden, suggests that snus use is substantially less hazardous than cigarette smoking because it is not associated with increased risks of lung cancer, oral cancer and chronic obstructive pulmonary disease.

In this study, reported in Chemistry Central Journal (10.1186/1752-153X-7-55), the constituents tested included nicotine, four tobacco-specific nitrosamines (TSNAs), propylene glycol, water, ammonium, nitrate, sodium, chloride, linalool, citronellol, linalyl acetate and geraniol. The researchers found that, generally, less than a third of each constituent was extracted by consumers during use.

'As well as being the first detailed description of methodology for extracting and quantifying such a range of analytes, the findings from this study give us an idea of the real-life exposure of consumers to snus constituents,' says Nathan Gale, a researcher at British American Tobacco Group Research & Development.

A multi-analyte approach was used, which involves concurrently extracting various tobacco constituents from the same snus pouch using methanol, ethanol and water. The technique, which was validated by comparing the data obtained this way with data obtained from the corresponding established single-analyte methods, was applied to a pilot study of users of Swedish pouched snus. The levels of constituents in snus pouches were determined before and after one hour of use by participants previous research has shown that the median residence time in the mouth is one hour.

The UK Royal College of Physicians has concluded that different categories of smokeless tobacco products (STPs) pose varying levels of risk to their users in line with their toxicant content. However, the findings from this research show that the toxicant content of STPs may not reflect what is actually ingested by consumers.

The results provide reference data for the development of a laboratory system that mimics the real-life extraction of tobacco constituents from snus. Such a system would be a cheaper and more efficient alternative to human studies.

In addition, the results show that exposure to snus constituents by consumers is a variable process. The researchers suggest that uptake may be affected by composition and amount of saliva, pressure and movement applied to the pouch during use, and different physiological characteristics of participants.

The next step is to apply the multi-analyte approach to different types of snus, in order to understand the effects of, for example, pouch size and water content. Further work is also needed to understand the importance of usage time, solubility of constituents in saliva, and real-life factors like consuming beverages or food while using snus.


'/>"/>

Contact: Dr Marina Murphy
marina_murphy@bat.com
44-077-111-50135
R&D at British American Tobacco
Source:Eurekalert

Related medicine news :

1. Many doctors do not provide tobacco cessation assistance to lung cancer patients
2. A billion deaths from tobacco are a key obstacle to global development
3. International Conference on Governance of Tobacco in the 21st Century
4. Californias Tobacco Control Program generates huge health care savings, UCSF study shows
5. Genetically modified tobacco plants produce antibodies to treat rabies
6. Researchers Identify Involuntary Tobacco Smoke Exposure in Boston Public Housing Authority Residents with Salivary Cotinine Testing from Salimetrics.
7. Treating tobacco addiction a duty, argue text editors
8. Smoking parents often expose children to tobacco smoke in their cars
9. Strong tobacco control policies in Brazil credited for more than 400,000 lives saved
10. Smoking and natural disasters: Christchurch residents increase tobacco consumption post-earthquake
11. Scientists ID Cancer-Causing Agent in Smokeless Tobacco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Successful recruitment ... new clinical and scientific initiatives have all marked the last 12 months at ... and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, outlined ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... life? The answer may be at the tips of your toes. Foot massage, whether ... as well as pure comfort and relaxation. The American Board of Multiple Specialties ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps ... in Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally ... one hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... search for and donate to Give To Cure’s campaign that is crowdfunding clinical trials ... users make and share payments through a smart device. In 2015 alone, Venmo processed ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Dr. Justin ... announce their 2nd Annual No Cost Dental Day to individuals in need. The event ... purpose of this No Cost Dental Day is to provide dental care to community ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016  SciClone Pharmaceuticals, Inc. ... it has entered into a settlement agreement with ... fully resolving the SEC,s investigation into possible violations ... the terms of the settlement agreement, SciClone has ... including disgorgement, pre-judgment interest and a penalty.  This ...
(Date:2/4/2016)... Feb. 4, 2016 Global Immunology Market ... to drive long-term market growth Summary ... of chronic disorders that affect 5–7% of western ... of their symptoms and key patient demographics, they ... immune pathways and an inappropriate immune response. Generally, ...
(Date:2/4/2016)... DIEGO, Feb. 4, 2016  Aethlon Medical, Inc. ... affinity biofiltration devices to treat life-threatening diseases, today ... 2016 ended December 31, 2015. ... objectives set forth in our last quarterly call, ... reinforce our long-term objective to establish the Aethlon ...
Breaking Medicine Technology: